돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 317생성일: 2026년 10월 23일

Piperazine → 4-Chloro-2-(piperazin-1-yl)benzonitrile

https://huagongshe.com/ko/reaction/317

반응식

참여 물질

역할이름HCID투입량
반응물PiperazineHCID 4837—
반응물2-Bromo-4-chlorobenzonitrileHCID 23498524—
시약Cesium carbonateHCID 10796—
촉매Binap, (A+-)-HCID 634876—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매1,4-DioxaneHCID 31275—
생성물4-Chloro-2-(piperazin-1-yl)benzonitrileHCID 179292380%

반응 조건

온도90 °C

반응 단계

Tris(dibenzylideneacetone)dipalladium (0) (43.4 mg, 0.05 mmol) and rac-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl (59.0 mg, 0.09 mmol) were added to a mixture of 2-bromo-4-chlorobenzonitrile (205 mg, 0.95 mmol), Cesium carbonate (463 mg, 1.42 mmol) and Piperazine (163 mg, 1.89 mmol) in dioxane (3 mL). Reaction vessel was placed in an oil bath set to 90 °C 2.45pm. LCMS o/n shows large product peak (222). Cooled, filtered through a silica plug, washing with EtOAc until filtrate is clear. Crude NMR is very messy, target deprioritized. Discarded.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-124e8e40d3e54042af531dbb1d8d85d1
출처 메모750 AstraZeneca ELN dataset